FDA Inspection
Shilpa Pharma Lifesciences LimitedShilpa Pharma Lifesciences Limited – FDA Inspection, May 3, 2013
Record Details
This FDA Inspection record concerns Shilpa Pharma Lifesciences Limited, with an inspection on May 3, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 3, 2013
- Product Type
- Drugs
View Company Profile
ID · 3494d904-0572-42be-80d0-83dae2fc308d
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 830428
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Shilpa Pharma Lifesciences Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 19, 2018 | Not classified | Office of Inspections and Investigations | |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shilpa Pharma Lifesciences Limited
- FDA Inspection 1268017 - 2025-03-14
- FDA Inspection 1122653 - 2020-02-07
- FDA Inspection 1099290 - 2019-07-26
- FDA Inspection 1038233 - 2018-01-19
- FDA Inspection 1004337 - 2016-12-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.